{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:20:03Z","timestamp":1786119603305,"version":"build-2736575974"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,9,24]]},"DOI":"10.1097\/qad.0b013e32833e9245","type":"journal-article","created":{"date-parts":[[2010,8,25]],"date-time":"2010-08-25T03:24:36Z","timestamp":1282706676000},"page":"2412-2414","source":"Crossref","is-referenced-by-count":28,"title":["HIV genetic diversity between plasma and cerebrospinal fluid in patients with HIV encephalitis"],"prefix":"10.1097","volume":"24","author":[{"given":"Cathia","family":"Souli\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Slim","family":"Fourati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidonie","family":"Lambert-Niclot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Tubiana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Canestri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Marie","family":"Girard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Katlama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Morand-Joubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Calvez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Genevi\u00e8ve","family":"Marcelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-17-20210130","first-page":"94","article-title":"HIV-associated neurocognitive disease continues in the antiretroviral era","volume":"16","author":"Clifford","year":"2008","journal-title":"Top HIV Med"},{"key":"R2-17-20210130","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1046\/j.1468-1293.2001.00056.x","article-title":"Antiretroviral treatment of central nervous system HIV-1 infection: a review","volume":"2","author":"Gisslen","year":"2001","journal-title":"HIV Med"},{"key":"R3-17-20210130","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1750-3639.2003.tb00010.x","article-title":"HIV-1 persistence, viral reservoir, and the central nervous system in the HAART era","volume":"13","author":"Lambotte","year":"2003","journal-title":"Brain Pathol"},{"issue":"Suppl 2","key":"R4-17-20210130","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/13550280290101094","article-title":"The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy","volume":"8","author":"Sacktor","year":"2002","journal-title":"J Neurovirol"},{"key":"R5-17-20210130","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/archneurol.2007.31","article-title":"Validation of the CNS penetration-effectiveness rank for quantifying antiretroviral penetration into the central nervous system","volume":"65","author":"Letendre","year":"2008","journal-title":"Arch Neurol"},{"key":"R6-17-20210130","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/QAI.0b013e31819fb903","article-title":"Presence of HIV-1 R5 viruses in cerebrospinal fluid even in patients harboring R5X4\/X4 viruses in plasma","volume":"51","author":"Soulie","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R7-17-20210130","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/BF01731581","article-title":"A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences","volume":"16","author":"Kimura","year":"1980","journal-title":"J Mol Evol"},{"key":"R8-17-20210130","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1093\/molbev\/msm092","article-title":"MEGA4: molecular evolutionary genetics analysis (MEGA) software version 4.0","volume":"24","author":"Tamura","year":"2007","journal-title":"Mol Biol Evol"},{"key":"R10-17-20210130","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/00002030-200104130-00010","article-title":"HIV-1 reverse transcriptase sequence in plasma and cerebrospinal fluid of patients with AIDS dementia complex treated with Abacavir","volume":"15","author":"Lanier","year":"2001","journal-title":"AIDS"},{"key":"R11-17-20210130","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1093\/brain\/awl136","article-title":"Genetic attributes of cerebrospinal fluid-derived HIV-1 env","volume":"129","author":"Pillai","year":"2006","journal-title":"Brain"},{"key":"R12-17-20210130","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1128\/JVI.79.3.1772-1788.2005","article-title":"Genetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy","volume":"79","author":"Strain","year":"2005","journal-title":"J Virol"},{"key":"R13-17-20210130","doi-asserted-by":"crossref","first-page":"4637","DOI":"10.1128\/JCM.38.12.4637-4639.2000","article-title":"Comparison of human immunodeficiency virus type 1 RNA sequence heterogeneity in cerebrospinal fluid and plasma","volume":"38","author":"Tang","year":"2000","journal-title":"J Clin Microbiol"},{"key":"R14-17-20210130","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1097\/QAD.0b013e3283299129","article-title":"Cross-sectional characterization of HIV-1 env compartmentalization in cerebrospinal fluid over the full disease course","volume":"23","author":"Harrington","year":"2009","journal-title":"AIDS"},{"key":"R15-17-20210130","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jviromet.2010.04.030","article-title":"Comparison of standard PCR\/cloning to single genome sequencing for analysis of HIV-1 populations","volume":"168","author":"Jordan","year":"2010","journal-title":"J Virol Methods"},{"key":"R16-17-20210130","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nri1527","article-title":"The neuropathogenesis of AIDS","volume":"5","author":"Gonzalez-Scarano","year":"2005","journal-title":"Nat Rev Immunol"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00002030-201009240-00017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:41:34Z","timestamp":1786041694000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002030-201009240-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,24]]},"references-count":15,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e32833e9245","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9,24]]}}}